|
|
|
|
||
Amarin needs to be readyIf the worst happens and the appeal fails, I think Amarin should be ready with a strategy. In such an unfortunate scenario, I would like to see a press release titled: Amarin to sell generic Vascepa at cost in the USA and move operations to Europe to concentrate on the more valuable Vascepa label in that region. Vascepa sales in China, Austrailia, Canada, Midde East, and rest of world will now be handled from our European base. |
return to message board, top of board |